Affiliation:
1. Departments of Microbiology and Immunology1 and
2. Chemistry,2 Dalhousie University, Halifax, Nova Scotia, Canada B3H 4H7
Abstract
ABSTRACT
Clostridium difficile
is a major nosocomial pathogen responsible for pseudomembranous colitis and many cases of antibiotic-associated diarrhea. Because of potential relapse of disease with current antimicrobial therapy protocols, there is a need for additional and/or alternative antimicrobial agents for the treatment of disease caused by
C. difficile
. We have synthesized a systematic series of 14 structurally simple bismuth compounds and assessed their biological activities against
C. difficile
and four other gastrointestinal species, including
Helicobacter pylori
. Here, we report on the activities of six compounds that exhibit antibacterial activities against
C. difficile
, and some of the compounds have MICs of less than 1 μg/ml. Also tested, for comparison, were the activities of bismuth subcitrate and ranitidine bismuth citrate obtained from commercial sources.
C. difficile
and
H. pylori
were more sensitive both to the synthetic bismuth compounds and to the commercial products than were
Escherichia coli
,
Pseudomonas aeruginosa
, and
Proteus mirabilis
, and the last three species were markedly resistant to the commercial bismuth salts. Testing with human foreskin fibroblast cells revealed that some of the synthetic compounds were more cytotoxic than others. Killing curves for
C. difficile
treated with the more active compounds revealed rapid death, and electron microscopy showed that the bismuth of these compounds was rapidly incorporated by
C. difficile
. Energy dispersive spectroscopy X-ray microanalysis of
C. difficile
cells containing electron-dense material confirmed the presence of internalized bismuth. Internalized bismuth was not observed in
C. difficile
treated with synthetic bismuth compounds that lacked antimicrobial activity, which suggests that the uptake of the metal is required for killing activity. The nature of the carrier would seem to determine whether bismuth is transported into susceptible bacteria like
C. difficile
.
Publisher
American Society for Microbiology
Subject
Infectious Diseases,Pharmacology (medical),Pharmacology
Reference28 articles.
1. The structurally flexible bicyclic bis(2-hydroxyethanethiolato)bismuth(III) complex: a model for asymmetric monoanionic chelation of bismuth(III).;Agocs L.;Inorg. Chem.,1997
2. Spectroscopic, structural, and mass spectrometric studies on two systematic series of dithiabismuth(III) heterocycles: identification of bismuthenium cations and their solvent complexes.;Agocs L.;J. Am. Chem. Soc.,1996
3. Bismuth (III) complexes of 2-mercaptoethanol: preparation, structural and spectroscopic characterization, antibacterial activity toward Helicobacter pylori, and inhibitory effect toward H. pylori-produced urease.;Asato R.;Bull. Chem. Soc. Jpn.,1997
4. Bismuth subsalicylate: history, chemistry, and safety.;Bierer D. W.;Rev. Infect. Dis.,1990
5. Pathogenesis of Clostridium difficile infection of the gut.;Borriello S. P.;J. Med. Microbiol.,1990
Cited by
63 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献